180 Life Sciences Issues Letter to Stockholders
Yahoo! Finance
PALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company today released the following letter to stockholders from its Chief Executive Officer, Dr. James Woody. Dear Fellow Stockholder, In mid-June, I wrote to update you on the status of our Company and our respective investments. In that letter, I provided an update regarding the Company’s clinical development plans, which remained
Continue Reading